ConductScience.org, home

Paper12009331

Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.

Liacini A and 3 others. Matrix Biol, 2002. Cited by 351 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Papers, record 12009331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12009331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.
PubMed
Journal
Matrix Biol
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
351
iCite
Relative citation ratio, by iCite
8.89
iCite
Revised in PubMed
2022-03-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liacini AAbdelhamid
2Sylvester JJudith
3Li WQWen Qing
4Zafarullah MMuhammad

Source PubMed

Download CSV of authors

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CollagenasesMajor topic
Down-RegulationMajor topic
Gene Expression Regulation, EnzymologicMajor topic
Interleukin-1Major topic
Matrix Metalloproteinase 3Major topic
Mitogen-Activated Protein KinasesMajor topic
NF-kappa BMajor topic
Osteoarthritis, HipMajor topic
Transcription Factor AP-1Major topic
Animals
Cartilage, Articular
Cattle
Cells, Cultured
Chondrocytes
Curcumin
Enzyme Activation
Enzyme Inhibitors
Femur Head
Humans
Imidazoles
JNK Mitogen-Activated Protein Kinases
Matrix Metalloproteinase 13
Pyridines
Pyrrolidines
Thiocarbamates
Time Factors
p38 Mitogen-Activated Protein Kinases

Source PubMed

Download CSV of topics

Cited by126

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.

PMIDTitleJournalYearIn PapersSource
42416050Inflammaging and osteoarthritis - therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42416050PubMed
42256397Isoviolanthin suppresses IL-1β-induced inflammatory and catabolic responses in chondrocytes.Front Pharmacol2026https://conductscience.org/library/papers/42256397PubMed
41843133Exploration of the therapeutic potential of magnoflorine against osteoarthritis progression using network pharmacology and in vitro validation.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41843133PubMed
41799761Artemisia argyi-enhanced Mesenchymal Stem Cell Exosomes Alleviates Inflammation in C28/I2 Chondrocytes by inhibiting NF-κB.Int J Med Sci2026https://conductscience.org/library/papers/41799761PubMed
41500539Interleukin-1β-induced arthritis involves chondrocyte oxiapoptophagy.Korean J Physiol Pharmacol2026https://conductscience.org/library/papers/41500539PubMed
41023741A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering.Stem Cell Res Ther2025https://conductscience.org/library/papers/41023741PubMed
39568849Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins.Heliyon2024https://conductscience.org/library/papers/39568849PubMed
39519121The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/39519121PubMed
39199189A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis.Antioxidants (Basel)2024https://conductscience.org/library/papers/39199189PubMed
38849589The emerging role of the semaphorin family in cartilage and osteoarthritis.Histochem Cell Biol2024https://conductscience.org/library/papers/38849589PubMed
38741587Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway.Front Pharmacol2024https://conductscience.org/library/papers/38741587PubMed
38718039Mume Fructus reduces interleukin-1 beta-induced cartilage degradation via MAPK downregulation in rat articular chondrocytes.PLoS One2024https://conductscience.org/library/papers/38718039PubMed
37560235Down-regulation of Jun induces senescence through destabilizing chromatin in osteoarthritis chondrocytes.Am J Transl Res2023https://conductscience.org/library/papers/37560235PubMed
37513300Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases.Molecules2023https://conductscience.org/library/papers/37513300PubMed
37362206The role of WNT and IL-1 signaling in osteoarthritis: therapeutic implications for platelet-rich plasma therapy.Front Aging2023https://conductscience.org/library/papers/37362206PubMed
37189419Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum.Biomolecules2023https://conductscience.org/library/papers/37189419PubMed
37026251Tear proteomics in dry eye disease.Indian J Ophthalmol2023https://conductscience.org/library/papers/37026251PubMed
35831464Glutamine exerts a protective effect on osteoarthritis development by inhibiting the Jun N-terminal kinase and nuclear factor kappa-B signaling pathways.Sci Rep2022https://conductscience.org/library/papers/35831464PubMed
35806899Potential Therapeutic Applications of Natural Compounds in Diabetes-Associated Periodontitis.J Clin Med2022https://conductscience.org/library/papers/35806899PubMed
35730575L-Glutamine alleviates osteoarthritis by regulating lncRNA-NKILA expression through the TGF-β1/SMAD2/3 signalling pathway.Clin Sci (Lond)2022https://conductscience.org/library/papers/35730575PubMed

See all 126 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12009331

GET https://conductscience.org/api/papers/v1/12009331/cited_by?page=2